Molecularly Tailored Therapy for Pancreas Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

June 30, 2016

Study Completion Date

January 24, 2018

Conditions

Pancreatic Cancer

Interventions

DRUG

Gem-OX

DRUG

Gem-5FU

DRUG

Gem-Tax

DRUG

Modified FOLFOX-6

DRUG

Ox-Tax

DRUG

FOLFIRI

DRUG

Tax-Iri

Trial Locations (2)

Georgetown University- Lombardi Comprehensive Cancer Center, Washington D.C.

MedStar Montgomery Medical Center, Olney

All Listed Sponsors

lead

Georgetown University

OTHER

NCT01888978 - Molecularly Tailored Therapy for Pancreas Cancer | Biotech Hunter | Biotech Hunter